Home/Filings/4/0001654954-17-008684
4//SEC Filing

Schelling Chris 4

Accession 0001654954-17-008684

CIK 0001069308other

Filed

Sep 20, 8:00 PM ET

Accepted

Sep 21, 5:23 PM ET

Size

5.0 KB

Accession

0001654954-17-008684

Insider Transaction Report

Form 4
Period: 2017-09-19
Schelling Chris
DirectorPresident and CEO
Transactions
  • Other

    Common Stock

    2017-09-19+1,750,0001,750,000 total
Footnotes (1)
  • [F1]Received in connection with the Issuer's business combination (the "Merger") with what was then known as "Acer Therapeutics Inc." ("Private Acer") in accordance with the terms of the Agreement and Plan of Merger and Reorganization dated June 30, 2017 among the Issuer, Opexa Merger Sub, Inc. and Private Acer, in exchange for 1,750,000 shares of common stock of Private Acer.

Issuer

Acer Therapeutics Inc.

CIK 0001069308

Entity typeother

Related Parties

1
  • filerCIK 0001717241

Filing Metadata

Form type
4
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 5:23 PM ET
Size
5.0 KB